Cite
HARVARD Citation
Gessner, C. et al. (n.d.). 119TiP An observational study to assess the effectiveness and safety of cemiplimab in patients with advanced non-small cell lung cancer (NSCLC) in routine clinical practice within Europe (CEMI-LUNG). Immuno-oncology technology. p. . [Online].